IRIS
DAGNA, LORENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.900
NA - Nord America 7.087
EU - Europa 5.698
SA - Sud America 1.961
AF - Africa 162
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 11
AN - Antartide 1
Totale 22.848
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.760
SG - Singapore 3.258
CN - Cina 2.466
BR - Brasile 1.642
RO - Romania 1.136
IT - Italia 1.131
SE - Svezia 1.128
HK - Hong Kong 993
DE - Germania 590
RU - Federazione Russa 482
VN - Vietnam 477
GB - Regno Unito 280
FI - Finlandia 228
CA - Canada 173
IN - India 153
AR - Argentina 143
NL - Olanda 121
AT - Austria 112
MX - Messico 111
PL - Polonia 100
JP - Giappone 99
FR - Francia 97
ZA - Sudafrica 77
TR - Turchia 69
ES - Italia 68
ID - Indonesia 62
BD - Bangladesh 60
EC - Ecuador 51
IE - Irlanda 51
IQ - Iraq 36
LT - Lituania 36
PK - Pakistan 31
UA - Ucraina 31
CO - Colombia 29
PH - Filippine 26
PY - Paraguay 26
VE - Venezuela 25
PE - Perù 24
MA - Marocco 21
AU - Australia 20
IL - Israele 20
AE - Emirati Arabi Uniti 19
BE - Belgio 19
IR - Iran 18
UZ - Uzbekistan 18
EG - Egitto 17
SA - Arabia Saudita 15
CL - Cile 14
KE - Kenya 12
NO - Norvegia 12
TN - Tunisia 12
BG - Bulgaria 9
DO - Repubblica Dominicana 9
DZ - Algeria 9
AZ - Azerbaigian 8
CH - Svizzera 8
HN - Honduras 8
BH - Bahrain 7
GR - Grecia 7
JO - Giordania 7
KR - Corea 7
KZ - Kazakistan 7
MY - Malesia 7
NZ - Nuova Zelanda 7
DK - Danimarca 6
JM - Giamaica 6
PT - Portogallo 6
UY - Uruguay 6
XK - ???statistics.table.value.countryCode.XK??? 6
CZ - Repubblica Ceca 5
EU - Europa 5
LU - Lussemburgo 5
MK - Macedonia 5
NP - Nepal 5
PA - Panama 5
BW - Botswana 4
LB - Libano 4
LV - Lettonia 4
OM - Oman 4
TW - Taiwan 4
BY - Bielorussia 3
GT - Guatemala 3
HU - Ungheria 3
MD - Moldavia 3
MO - Macao, regione amministrativa speciale della Cina 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AL - Albania 2
AM - Armenia 2
CU - Cuba 2
GA - Gabon 2
GE - Georgia 2
KG - Kirghizistan 2
SV - El Salvador 2
TG - Togo 2
TH - Thailandia 2
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
Totale 22.826
Salva come PNG Salva come JPEG
Città #
Dallas 2.458
Singapore 1.573
Hong Kong 983
Ashburn 757
Shanghai 639
Hefei 436
Beijing 384
New York 365
Milan 316
Lawrence 278
Princeton 278
Los Angeles 223
Munich 197
Ho Chi Minh City 187
Boardman 184
Moscow 178
São Paulo 149
Nuremberg 145
Helsinki 124
Hanoi 98
Rome 93
Warsaw 79
Denver 75
Montreal 70
London 69
Tokyo 68
Brooklyn 65
Rio de Janeiro 65
Santa Clara 65
Poplar 61
Guangzhou 58
Turku 54
Atlanta 50
Johannesburg 50
Dublin 47
Lappeenranta 46
Mexico City 44
Seattle 44
Vienna 41
Amsterdam 40
Ankara 40
Pune 40
Stockholm 40
Boston 38
Frankfurt am Main 37
Houston 36
Phoenix 36
Washington 36
Chicago 35
Toronto 35
Chennai 33
Falkenstein 33
Belo Horizonte 32
Brasília 29
Cesano Boscone 29
Orem 28
Manchester 24
Xi'an 24
Ancona 23
Haiphong 23
Mumbai 23
Querétaro 22
Curitiba 21
The Dalles 21
Buffalo 20
Campinas 20
Salvador 20
Jakarta 19
Porto Alegre 18
Shenzhen 18
Turin 18
Cape Town 17
Florence 17
San Francisco 17
Wolfhagen 17
Tashkent 16
Tianjin 16
Bexley 15
Brussels 15
Council Bluffs 15
Jiaxing 15
Lahore 15
Vaprio d'Adda 15
Buenos Aires 14
Changsha 14
Columbus 14
Guayaquil 14
Rotterdam 14
Joinville 13
Kassel 13
Lima 13
Secaucus 13
Bologna 12
Brescia 12
Genoa 12
Hangzhou 12
Sorocaba 12
Zhengzhou 12
Bauru 11
Bogotá 11
Totale 12.413
Salva come PNG Salva come JPEG
Nome #
Real-world effectiveness and persistence of golimumab as second-line anti-TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO-BEYOND, a 12-month prospective observational study 546
Digital Ulcers and Ventricular Arrhythmias as Red Flags to Predict Replacement Myocardial Fibrosis in Systemic Sclerosis 418
Intercalated Disc Abnormalities Are Linked to Arrhythmias in Inflammatory Cardiomyopathy 380
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors 325
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 319
The association between body mass index and fibromyalgia severity: Data from a cross-sectional survey of 2339 patients 306
Monkeypox in a patient with undifferentiated connective tissue disease 216
Serum organ-specific anti-heart and anti-intercalated disk autoantibodies as new autoimmune markers of cardiac involvement in systemic sclerosis: Frequency, clinical and prognostic correlates 207
Sociodemographic factors in fibromyalgia: results from the Italian Fibromyalgia Registry 182
EA4HP24-LYWS-293 An indolent EBV-related clonal T-cell proliferation presenting as chronic rhinosinusitis 147
Heart Rate Variability in Subjects with Severe Allergic Background Undergoing COVID-19 Vaccination 135
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 131
A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients 121
Virus-encoded chemokines, chemokine receptors and chemokine-binding proteins: new paradigms for future therapy 115
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency 114
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 113
Gas-exchange deficit and systemic hypoperfusion in COVID-19 and non-COVID-19 young adult patients with pneumonia 108
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 106
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 106
IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients 102
ABS0671 IgG4-RELATED DISEASE IN OVERLAP WITH IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: CLINICAL-PATHOLOGICAL CHARACTERISTICS AND THERAPEUTIC IMPLICATIONS OF AN ORPHAN DISEASE 95
Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities 94
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 94
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 94
Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy 93
Two-year multidisciplinary follow-up of COVID-19 patients requiring invasive and noninvasive respiratory support 92
A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment 92
Anakinra for patients with COVID-19: an updated systematic review and meta-analysis 90
Pentraxin-3 as a Marker of Disease Activity in Takayasu Arteritis 88
A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM) 86
A bitter effect: thrombocytopenia induced by a quinidine-containing beverage 85
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study 85
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 85
Biobanking for COVID-19 research 84
[Cardiovascular involvement in Erdheim-Chester syndrome: clinical and therapeutic implications]. FT Coinvolgimento cardiovascolare nella sindrome di Erdheim-Chester: aspetti clinici e terapeutici. 83
Angiotensin II infusion and markers of organ function in invasively ventilated COVID-19 patients 82
Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy 81
Continuous positive airway pressure and pronation outside the Intensive Care Unit in COVID-19 acute respiratory distress syndrome 80
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 80
Cardiac magnetic resonance in systemic sclerosis myocarditis: the value of T2 mapping to detect myocardial inflammation 80
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 79
Prone positioning in awake COVID-19 patients: a systematic review and meta-analysis 79
C3-glomerulopathy and MGUS: The skin beyond the kidney 79
A Novel Histiocytosis With Synovial and Skin Involvement 79
Post-traumatic stress disorder in patients with systemic lupus erythematosus heavily affects quality of life. A cross-sectional web survey-based study 78
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 78
Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: The Role of Endomyocardial Biopsy 78
A cd8 alpha-negative subset of cd4+slamf7+ cytotoxic t cells is expanded in patients with igg4-related disease and decreases following glucocorticoid treatment 78
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 78
ASSOCIAZIONE TRA MALATTIA IGG4-CORRELATA E IMMUNOTERAPIA ALLERGENE-SPECIFICA. STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO. 77
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series 77
Distinctive clinical traits of lupus-related myocarditis: a multicentre retrospective study 77
3D culture of Erdheim-Chester disease tissues unveils histiocyte metabolism as a new therapeutic target 75
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 75
Clinical profiling and outcomes of viral myocarditis manifesting with ventricular arrhythmias 74
One-Year Multidisciplinary Follow-Up of Patients With COVID-19 Requiring Invasive Mechanical Ventilation 74
Adult leukoencephalopathies with prominent infratentorial involvement can be caused by Erdheim-Chester disease 73
Diamine Oxidase Supplementation in Chronic Spontaneous Urticaria: A Randomized, Double-Blind Placebo-Controlled Study 73
Efficacy and Safety of Methotrexate for the Treatment of Autoimmune Virus-Negative Myocarditis: A Case Series 72
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 72
Allergy and dimethyl fumarate treatment in a patient with multiple sclerosis 72
Assessing the role of pentraxin-3 in Takayasu's arteritis. Comment on: Plasma pentraxin-3 levels in patients with Takayasu's arteritis during routine follow-up. Alibaz-Oner F. et al 72
Beyond Neuropsychiatric Manifestations of Systemic Lupus Erythematosus: Focus on Post-traumatic Stress Disorder and Alexithymia 72
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 71
Effectiveness and safety of infliximab dose escalation in patients with refractory Takayasu arteritis: A real-life experience from a monocentric cohort 71
Basal Serum Diamine Oxidase Levels as a Biomarker of Histamine Intolerance: A Retrospective Cohort Study 71
Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies 71
Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis 70
Interactions between Severe Allergy and Anxiety in Anti-SARS-CoV-2 Vaccinees 70
Exercise Stress Test Late after Arrhythmic versus Nonarrhythmic Presentation of Myocarditis 70
Advances in potential targeted therapies for Erdheim-Chester disease 70
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 70
Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: A real-life multicentre study 69
Testosterone in males with COVID-19: A twelve-month cohort study 69
A relapsing inflammatory syndrome and HHV-8 69
Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases 69
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life 68
Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study 68
IMMUNOTERAPIA SPECIFICA E MALATTIA IgG4-CORRELATA: STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO 68
Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center 67
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study 67
Canakinumab injection for the treatment of active Still’s disease, including adult-onset Still’s disease 67
A virus-free cellular model recapitulates several features of severe COVID-19 67
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 66
Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis 66
Clinically isolated aortitis successfully treated with methotrexate monotherapy 66
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 66
CLINICAL PHENOTYPES OF IGG4- RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL FEATURES, SEROLOGICAL FINDINGS,AND PROGNOSTIC OUTCOMES 66
Anifrolumab for Moderate and Severe Muco-Cutaneous Lupus Erythematosus: A Monocentric Experience and Review of the Current Literature 65
Canakinumab as first-line biological therapy in Still’s disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registry 65
Inflammation as a Predictor of Recurrent Ventricular Tachycardia After Ablation in Patients With Myocarditis 65
DRUG RETENTION RATES OF BIOLOGICAL AGENTS IN ADULT ONSET STILL'S DISEASE IN THE PRE-CANAKINUMAB ERA 65
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 65
The spectrum of covid-19-associated myocarditis: A patient-tailored multidisciplinary approach 65
Immunosuppressive strategies in invasively ventilated ARDS COVID-19 patients 65
Cardiac Safety of mRNA-based Vaccines in Patients with Systemic Lupus Erythematosus and Lupus-like Disorders with a History of Myocarditis 65
Cardiovascular involvement in Erdheim-Chester diseases is associated with myocardial fibrosis and atrial dysfunction 65
The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study 64
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production 64
Adult-onset Still's disease: clinical presentation in a large cohort of Italian patients 64
Totale 10.170
Salva come PNG Salva come JPEG
Categoria #
all - tutte 157.004
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 157.004
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202191 0 0 0 0 0 27 31 6 6 4 13 4
2021/2022431 3 0 101 78 26 27 33 26 42 37 30 28
2022/20232.175 652 435 141 21 36 244 220 209 102 39 40 36
2023/20242.244 79 135 231 200 184 373 118 204 18 92 210 400
2024/20257.670 639 146 220 243 291 550 2.019 711 1.014 686 486 665
2025/202610.909 1.583 2.171 2.331 2.866 1.780 178 0 0 0 0 0 0
Totale 23.657